Health Care Industry News
When drug makers' profits outweigh penalties
Washington Post, The | 1 hour 4 minutes ago
Prosecutor Michael Loucks remembers clearly when attorneys for Pfizer, the world's largest drug company, looked across the table and promised it wouldn't break the law again. ... (more)
Latest Health Care Industry NewsMore >
The week that was: In case you missed it ...
Pittsburgh Post-Gazette | 1 hour 5 minutes ago
Insurance News
InsuranceNewsNet | 2 hours 31 minutes ago
Herbalife Kicks Off 30th Anniversary Celebration
Investor's Business Daily | 3 hours 2 minutes ago
FDA panel unanimously back approval for Medtronic's scan-friendly pacemaker
Star Tribune (Minneapolis-St. Paul, Minn.) | 5 hours 4 minutes ago
When drug makers' profits outweigh penalties: Pharmaceutical giants Pfizer and Lilly can spend $1 billion developing a new pill. To recoup their investment, they wanted doctors to prescribe their drugs for uses not approved by the FDA. The illegal practice cost them billions in fines. With vast sums at stake, it's simply the cost of doing business.
Washington Post, The | 15 hours 5 minutes ago
Readers ChoiceMore >
FDA issues complete-response letter for Byetta LAR
FDLI SmartBrief | Mar 16, 2010
Researchers measure lead in Indian spices
FDLI SmartBrief | Mar 15, 2010
FDA adds metabolism warning to Plavix
FDLI SmartBrief | Mar 15, 2010
FDA orders Glenmark, Konec to stop selling nitroglycerin tablets
FDLI SmartBrief | Mar 17, 2010
FDA policy would accelerate approval of drug cocktails
FDLI SmartBrief | Mar 18, 2010
FDLI News
More >
Join FDLI, get involved, make a difference!
FDLI SmartBrief | Mar 19, 2010
Attention regulatory affairs managers, law firm associates and Capitol Hill staffers new to drug law and regulation: Attend Introduction to Drug Law and Regulation, June 22 and 23
FDLI SmartBrief | Mar 19, 2010
Are you dealing with a recall?
FDLI SmartBrief | Mar 18, 2010
Tobacco Law, Regulation & Policy Resource Center updated
FDLI SmartBrief | Mar 18, 2010
What is the status of custom devices regulation after Endotec? Register for the March 29 Webinar
FDLI SmartBrief | Mar 17, 2010
Latest Health Care Industry Press ReleasesMore >
Glancy Binkow & Goldberg LLP, Representing Investors Who Purchased Cell Therapeutics, Inc., Announces Class Action Lawsuit and Seeks to Recover Losses
Business Wire | 1 day 5 hours 11 minutes ago
Medtronic Receives FDA Panel s Unanimous Recommendation for Approval of Revo MRI SureScan Pacing System
Business Wire | 1 day 7 hours 11 minutes ago
Madison Pacific Properties Inc. (TSX: MPC) Announces Equity Investment in Metro Vancouver Properties Inc.
MarketWire | 1 day 7 hours 11 minutes ago
The Medicines Company Provides Update on PTO Litigation
MarketWire | 1 day 7 hours 41 minutes ago
Biogen Idec to Present at the Barclays Capital 2010 Global Healthcare Conference
Business Wire | 1 day 9 hours 11 minutes ago
Astellas Announces Changes to Director Nominees for Election to OSI Pharmaceuticals' Board of Directors
PRNewswire | 1 day 9 hours 41 minutes ago
Sign up for FDLI SmartBrief
Latest Blog Postsview more
Human ancestors walked comfortably upright 3.6 million years ago, new footprint study says
Science Blog
Researchers find infrared thermal detection systems useful for patient screening
Science Blog
LHC surpasses its own record as the world's most powerful particle accelerator
Science Blog
Designer nanomaterials on-demand
Science Blog
Companies in the news
- Actavis Group
- Aetna Incorporated
- Alpharma Inc
- Biotime Inc
- CANGENE CORPORATION
- Enzo Biochem Inc
- FujiFilm Medical Systems USA
- Highmark Inc.
- Hikma
- Kinetic Concepts Inc
- Metropolitan Health Networks, Inc.
- Novartis
- Novartis AG
- Pfizer
- Teva Pharmaceutical Industries Ltd.
Recent Poll view more polls